Human urinary metabolomic profile of PPARRα induced fatty acid β-oxidation

Journal of Proteome Research

Volumn 8, Issue 9, 2009, Pages 4293-4300

  Patterson, Andrew D ^a   Slanař, Ondřej ^b   Krausz, Kristopher W ^a   Li, Fei ^a   Höfer, Constance C ^c   Perlík, František ^b   Gonzalez, Frank J ^a   Idle, Jeffrey R ^b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b CHARLES UNIVERSITY   (Czech Republic)

^c DMPKORE   (Germany)

Author keywords

Fenofibrate; Metabolomics; Pharmacometabolomics; PPAR; Random forests

Indexed keywords

2 METHYLBUTYRYLCARNITINE; ACYLCARNITINE; CARNITINE DERIVATIVE; CHOLESTEROL; FATTY ACID; FENOFIBRATE; ISOBUTYRYLCARNITINE; ISOVALERYLCARNITINE; PANTOTHENATE KINASE; PANTOTHENIC ACID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PROPYLCARNITINE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; URIC ACID;

ALGORITHM; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; ELECTROSPRAY MASS SPECTROMETRY; FATTY ACID OXIDATION; FEMALE; GENE; HUMAN; HUMAN CELL; HUMAN TISSUE; LIQUID CHROMATOGRAPHY; MALE; METABOLOMICS; MOUSE; NONHUMAN; NORMAL HUMAN; PRIORITY JOURNAL; TIME OF FLIGHT MASS SPECTROMETRY; TRIACYLGLYCEROL BLOOD LEVEL; URIC ACID BLOOD LEVEL; URINALYSIS; URINE LEVEL;

ADULT; ALGORITHMS; ANALYSIS OF VARIANCE; ANIMALS; ANTILIPEMIC AGENTS; ARTIFICIAL INTELLIGENCE; BIOLOGICAL MARKERS; CARNITINE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FATTY ACIDS; FEMALE; HUMANS; MALE; MASS SPECTROMETRY; METABOLOME; METABOLOMICS; MICE; MICE, INBRED C57BL; PANTOTHENIC ACID; PPAR ALPHA; PROCETOFEN; URINE;

EID: 70349908127     PISSN: 15353893     EISSN: None     Source Type: Journal    
DOI: 10.1021/pr9004103     Document Type: Article

References (28)

1. Michalik, L.; Auwerx, J.; Berger, J. P.; Chatterjee, V. K.; Glass, C. K.; Gonzalez, F. J.; Grimaldi, P. A.; Kadowaki, T.; Lazar, M. A.; O'Rahilly, S.; Palmer, C. N.; Plutzky, J.; Reddy, J. K.; Spiegelman, B. M.; Staels, B.; Wahli, W. International Union of Pharmacology. LXI Peroxisome proliferator-activated receptors. Pharmacol. Rev. 2006, 58 (4), 726-741 (Pubitemid 44833742)
2. Peters, J. M.; Hennuyer, N.; Staels, B.; Fruchart, J. C.; Fievet, C.; Gonzalez, F. J.; Auwerx, J. Alterations in lipoprotein metabolism in peroxisome proliferator-activated receptor alpha-deficient mice. J. Biol. Chem. 1997, 272 (43), 27307-27312 (Pubitemid 27452695)
3. Staels, B.; Vu-Dac, N.; Kosykh, V. A.; Saladin, R.; Fruchart, J. C.; Dallongeville, J.; Auwerx, J. Fibrates downregulate apolipoprotein C-III expression independent of induction of peroxisomal acyl coenzyme A oxidase. A potential mechanism for the hypolipidemic action of fibrates. J. Clin. Invest. 1995, 95 (2), 705-712
4. Kersten, S.; Mandard, S.; Escher, P.; Gonzalez, F. J.; Tafuri, S.; Desvergne, B.; Wahli, W. The peroxisome proliferator-activated receptor alpha regulates amino acid metabolism. Faseb J. 2001, 15 (11), 1971-1978 (Pubitemid 32848801)
5. Kersten, S.; Seydoux, J.; Peters, J. M.; Gonzalez, F. J.; Desvergne, B.; Wahli, W. Peroxisome proliferator-activated receptor alpha mediates the adaptive response to fasting. J. Clin. Invest. 1999, 103 (11), 1489-1498
6. Lee, S. S.; Pineau, T.; Drago, J.; Lee, E. J.; Owens, J. W.; Kroetz, D. L.; Fernandez-Salguero, P. M.; Westphal, H.; Gonzalez, F. J. Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators. Mol. Cell. Biol. 1995, 15 (6), 3012-3022
7. Filippatos, T.; Milionis, H. J. Treatment of hyperlipidaemia with fenofibrate and related fibrates. Expert Opin. Investig. Drugs 2008, 17 (10), 1599-1614
8. Guerre-Millo, M.; Gervois, P.; Raspe, E.; Madsen, L.; Poulain, P.; Derudas, B.; Herbert, J. M.; Winegar, D. A.; Willson, T. M.; Fruchart, J. C.; Berge, R. K.; Staels, B. Peroxisome proliferator-activated receptor alpha activators improve insulin sensitivity and reduce adiposity. J. Biol. Chem. 2000, 275 (22), 16638-16642 (Pubitemid 30398891)
9. Keun, H. C.; Athersuch, T. J. Application of metabonomics in drug development. Pharmacogenomics 2007, 8 (7), 731-741
10. Lindon, J. C.; Holmes, E.; Nicholson, J. K. Metabonomics in pharmaceutical R&D. Febs J. 2007, 274 (5), 1140-1151
11. Kaddurah-Daouk, R.; Kristal, B. S.; Weinshilboum, R. M. Metabolomics: a global biochemical approach to drug response and disease. Annu. Rev. Pharmacol. Toxicol. 2008, 48, 653-683
12. Enot, D. P.; Lin, W.; Beckmann, M.; Parker, D.; Overy, D. P.; Draper, J. Preprocessing, classification modeling and feature selection using flow injection electrospray mass spectrometry metabolite fingerprint data. Nat. Protoc. 2008, 3 (3), 446-470
13. Zhen, Y.; Krausz, K. W.; Chen, C.; Idle, J. R.; Gonzalez, F. J. Metabolomic and genetic analysis of biomarkers for peroxisome proliferator-activated receptor alpha expression and activation. Mol. Endocrinol. 2007, 21 (9), 2136-2151
14. Delaney, J.; Hodson, M. P.; Thakkar, H.; Connor, S. C.; Sweatman, B. C.; Kenny, S. P.; McGill, P. J.; Holder, J. C.; Hutton, K. A.; Haselden, J. N.; Waterfield, C. J. Tryptophan-NAD+ pathway metabolites as putative biomarkers and predictors of peroxisome proliferation. Arch. Toxicol. 2005, 79 (4), 208-223
15. Connor, S. C.; Hodson, M. P.; Ringeissen, S.; Sweatman, B. C.; McGill, P. J.; Waterfield, C. J.; Haselden, J. N. Development of a multivariate statistical model to predict peroxisome proliferation in the rat, based on urinary 1H-NMR spectral patterns. Biomarkers 2004, 9 (4-5), 364-385
16. Ringeissen, S.; Connor, S. C.; Brown, H. R.; Sweatman, B. C.; Hodson, M. P.; Kenny, S. P.; Haworth, R. I.; McGill, P.; Price, M. A.; Aylott, M. C.; Nunez, D. J.; Haselden, J. N.; Waterfield, C. J. Potential urinary and plasma biomarkers of peroxisome proliferation in the rat: identification of N-methylnicotinamide and N-methyl-4- pyridone-3-carboxamide by 1H nuclear magnetic resonance and high performance liquid chromatography. Biomarkers 2003, 8 (3-4), 240-271
17. Patterson, A. D.; Li, H.; Eichler, G. S.; Krausz, K. W.; Weinstein, J. N.; Fornace, A. J., Jr.; Gonzalez, F. J.; Idle, J. R. UPLC-ESI-TOFMS-based metabolomics and gene expression dynamics inspector selforganizing metabolomic maps as tools for understanding the cellular response to ionizing radiation. Anal. Chem. 2008, 80 (3), 665-674
18. Tyburski, J. B.; Patterson, A. D.; Krausz, K. W.; Slavik, J.; Fornace, A. J.; Gonzalez, F. J.; Idle, J. R. Radiation metabolomics. 1. Identification of minimally invasive urine biomarkers for gamma-radiation exposure in mice. Radiat. Res. 2008, 170 (1), 1-14.
19. Breiman, L. Random Forests. Machine Learning 2001, 45 (1), 5-32.
20. Eichler, G. S.; Reimers, M.; Kane, D.; Weinstein, J. N. The LeFE algorithm: embracing the complexity of gene expression in the interpretation of microarray data. Genome Biol. 2007, 8 (9), R187.
21. Enot, D. P.; Beckmann, M.; Overy, D.; Draper, J. Predicting interpretability of metabolome models based on behavior, putative identity, and biological relevance of explanatory signals. Proc. Natl. Acad. Sci. U.S.A. 2006, 103 (40), 14865-14870 (Pubitemid 44527820)
22. Cui, Q.; Lewis, I. A.; Hegeman, A. D.; Anderson, M. E.; Li, J.; Schulte, C. F.; Westler, W. M.; Eghbalnia, H. R.; Sussman, M. R.; Markley, J. L. Metabolite identification via the Madison Metabolomics Consortium Database. Nat. Biotechnol. 2008, 26 (2), 162-164
23. Kind, T.; Fiehn, O. Seven Golden Rules for heuristic filtering of molecular formulas obtained by accurate mass spectrometry. BMC Bioinformatics 2007, 8, 105. (Pubitemid 46584995)
24. Kiortsis, D. N.; Elisaf, M. S. Serum uric acid levels: a useful but not absolute marker of compliance with fenofibrate treatment. Fundam. Clin. Pharmacol. 2001, 15 (6), 401-403
25. Kota, B. P.; Huang, T. H.; Roufogalis, B. D. An overview on biological mechanisms of PPARs. Pharmacol. Res. 2005, 51 (2), 85-94.
26. Mandard, S.; Muller, M.; Kersten, S. Peroxisome proliferatoractivated receptor alpha target genes. Cell. Mol. Life Sci. 2004, 61 (4), 393-416. (Pubitemid 38316578)
27. Ramaswamy, G.; Karim, M. A.; Murti, K. G.; Jackowski, S. PPARalpha controls the intracellular coenzyme A concentration via regulation of PANK1alpha gene expression. J. Lipid Res. 2004, 45 (1), 17-31. (Pubitemid 38176611)
28. Ryals, J.; Lawton, K.; Stevens, D.; Milburn, M. Metabolon, Inc. Pharmacogenomics 2007, 8 (7), 863-866